Stock Ratings / Health Care / PAVM / earnings

MODD (36) RVP (33) CTSO (21) CNSY (36) ⌘ Pro Terminal →

PAVmed Inc. (PAVM) Next Earnings Date & Expected ±12.5% Move

Q: When is PAVM's next earnings date?

Based on SEC filing cadence, PAVmed Inc. (PAVM)'s next quarterly reporting window is estimated around Dec 30, 2026.

Q: How much is PAVM stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for PAVM, spanning a range between $1.72 and $2.22.

$1.97 -5.29% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

PAVmed Inc. (PAVM) carries a Roarable Rating of E (Strong Sell) with 31/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $15.8M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-12.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PAVM)Realized 20D OHLCV Swing Band: ±12.5%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.25 Expected Swing

MODEL EARNINGS SETUP GAUGE

PAVM Quantitative Pre-Earnings Setup: 31/100

Trailing EPS: $4.25 • YoY Revenue Growth: -65%

Model Bullish Setup (31/100)Model Risk Weight (69/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$71.0K	-$3.8M	-$5.2M	-50%
FY 2024	2024-12-31	$3.0M	$32.0M	-$33.6M	-50%
FY 2023	2023-12-31	$2.5M	-$66.3M	-$52.0M	8%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PAVM)

✓Walkthrough of PAVM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PAVM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -76.27%🛡️ HOLDING TREND SUPPORT

2026-10-30O $2.00H $2.08L $1.95C $1.97VOL 6.5K

RES: $4.44SUP: $1.61SMA50: $3.57SMA200: $6.57

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PAVM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PAVM Butterfly Map → + Track PAVM →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -65.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PAVM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PAVM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PAVM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PAVM)

Health Care Rank #935 of 1016 ⚔️ MODD vs PAVM Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PAVM vs. MODD, RVP, CTSO, CNSY)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, PAVmed Inc. (PAVM) ranks #935 by composite RQD confidence (31/100, grade E) and #856 by equity capitalization ($15.8M). Within this direct 5-issuer industry benchmark cohort, PAVM leads on earnings valuation at N/A trailing P/E, while RVP leads on capital efficiency and profitability with -23.3% ROIC and 0.1% gross margin. MODD currently holds the highest overall quantitative score in the immediate peer group at 36/100 (D-) compared with PAVM at 31/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PAVM ACTIVE PAVmed Inc.	E	31/100	—	-30.0%	-35.0%	-5.29%	$15.8M	Benchmark Subject
MODD Modular Medical Inc.	D-	36/100	—	—	-35.0%	-9.95%	$16.3M	/modd-vs-pavm →
RVP Retractable Technologies Inc.	E	33/100	—	0.1%	-23.3%	-1.15%	$17.3M	/rvp-vs-pavm →
CTSO Cytosorbents Corporation	E	21/100	—	71.5%	-35.0%	-16.03%	$13.9M	/ctso-vs-pavm →
CNSY Cerenome Inc.	D-	36/100	—	—	-35.0%	0.00%	$13.2M	/cnsy-vs-pavm →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001624326

In its most recent audited fiscal period (FY2025, filed 2025-12-31), PAVmed Inc. (PAVM) reported GAAP revenue of $71.0K (-97.6% vs. FY2024 revenue of $3.0M , and -97.1% cumulative change since FY2023) , GAAP net income of -$3.8M, operating cash flow of -$5.2M, and free cash flow of -$5.2M (+84.4% YoY). On the balance sheet, PAVM closed FY2025 with $38.8M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$71.0K	-$3.8M	-$5.2M	-$5.2M	$38.8M	—
FY2024 (FY)	2024-12-31	$3.0M	$32.0M	-$33.6M	-$33.6M	$30.7M	—
FY2023 (FY)	2023-12-31	$2.5M	-$66.3M	-$52.0M	-$52.0M	—	—

3. PAVM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PAVM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, PAVmed Inc. (NASDAQ: PAVM) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $1.97 (-5.29% 1D, market cap $15.8M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, PAVM ranks #935 in composite RQD confidence.

How does PAVM compare to MODD and RVP in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), PAVM carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of -30.0%, and ROIC of -35.0%. By comparison, MODD (Modular Medical Inc.) holds a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $16.3M) and RVP (Retractable Technologies Inc.) posts a E grade (33/100 RQD, P/E N/A, ROIC -23.3%, cap $17.3M). Among the 5-stock peer group, PAVM leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PAVM?

Per PAVM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001624326), PAVmed Inc. generated $71.0K in revenue (-97.6% YoY), -$3.8M in net income, and -$5.2M in free cash flow against $38.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PAVM trading relative to its 50-day, 200-day, and 52-week technical levels?

PAVM last traded at $1.97 (-5.29% on volume of 5,357 shares), positioning the stock -44.82% below its 50-day simple moving average ($3.57) and -70.02% below its 200-day simple moving average ($6.57). Across its 52-week range of $1.84 to $28.44, PAVM sits at the 0.5% percentile with a 14-day RSI of 26.5 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.72 to $2.22).

PAVM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is PAVM's next earnings date?

Based on SEC filing cadence, PAVmed Inc. (PAVM)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is PAVM stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for PAVM, spanning a range between $1.72 and $2.22.

Direct Sub-Reports: PAVM RQD Cockpit PAVM 12M Forecast PAVM Earnings & Move PAVM Dividends & DRIP PAVM Insiders & 13F PAVM Whale Options PAVM Profit Sankey PAVM News & Why